{"id":164,"date":"2020-09-08T22:53:24","date_gmt":"2020-09-08T20:53:24","guid":{"rendered":"https:\/\/oncomed-new.ddev.site\/?page_id=164"},"modified":"2024-01-16T09:32:52","modified_gmt":"2024-01-16T08:32:52","slug":"nas-pribeh","status":"publish","type":"page","link":"https:\/\/www.oncomed.cz\/cs\/nas-pribeh\/","title":{"rendered":"n\u00e1\u0161 p\u0159\u00edb\u011bh"},"content":{"rendered":"
\n
\n
\n
<\/div>\n <\/div>\n
\n
\n
\n
\n
\n

n\u00e1\u0161 p\u0159\u00edb\u011bh<\/h1>\n

Jak se to v\u0161e odehr\u00e1lo?<\/h2>\n <\/div>\n <\/div>\n
\n
\n
\n

Na\u0161e vzpom\u00ednky v\u00e1\u017e\u00edc\u00ed se k po\u010d\u00e1tk\u016fm oncomedu neza\u010d\u00ednaj\u00ed v roce 2010, ale sahaj\u00ed u\u017e do roku 2009. Nov\u00fd vlastn\u00edk spole\u010dnosti PLIVA-Lachema a. s., uva\u017eoval o tom, \u017ee ji zav\u0159e. Jedinou z\u00e1chranou pro n\u00e1s jako zam\u011bstnance m\u011bl b\u00fdt prodej spole\u010dnosti nov\u00e9mu vlastn\u00edkovi.<\/span><\/p>\n<\/div>\n \n \n A jak to v\u0161e dopadlo?\n <\/span>\n \n \n \n <\/path>\n <\/g>\n <\/g>\n <\/svg>\n <\/a>\n <\/div>\n <\/div>\n

\n
\n

N\u011bkte\u0159\u00ed z n\u00e1s se rozhodli p\u0159istoupit k t\u00e9to situaci aktivn\u011b. V hlav\u011b se n\u00e1m uhn\u00edzdila my\u0161lenka, \u017ee by bylo mo\u017en\u00e9 koupit alespo\u0148 to nejcenn\u011bj\u0161\u00ed, co PLIVA-Lachema a. s. m\u011bla, a to v\u00fdrobnu cytostatick\u00fdch injekc\u00ed. Obeslali jsme tedy v tomto duchu farmaceutick\u00e9 firmy, kter\u00e9 mohly m\u00edt o jej\u00ed koupi z\u00e1jem.<\/span><\/p>\n

K na\u0161emu p\u0159ekvapen\u00ed se ozvala spole\u010dnost medac Gesellschaft f\u00fcr klinische Spezialpr\u00e4parate mbH. medac vyj\u00e1d\u0159il z\u00e1jem a vyzval n\u00e1s k dal\u0161\u00edmu jedn\u00e1n\u00ed spo\u010d\u00edvaj\u00edc\u00ed ve vypracov\u00e1n\u00ed podnikatelsk\u00e9ho pl\u00e1nu a sehn\u00e1n\u00ed kl\u00ed\u010dov\u00fdch zam\u011bstnanc\u016f, na nich\u017e m\u011bla nov\u00e1 spole\u010dnost stav\u011bt. To bylo N\u011aCO. Za\u010dali jsme m\u00edt nad\u011bji, \u017ee n\u00e1\u0161 sen vybudovat konkurenceschopnou farmaceutickou firmu, j\u00ed\u017e z\u00e1le\u017e\u00ed nejen na kvalit\u011b, ale rovn\u011b\u017e na profitabilit\u011b, pov\u011bsti a vlastn\u00edm n\u00e1zoru, se m\u016f\u017ee st\u00e1t realitou. A tak za\u010dala kole\u010dka setk\u00e1v\u00e1n\u00ed, pl\u00e1nov\u00e1n\u00ed, vy\u010d\u00edslov\u00e1n\u00ed. Veden\u00ed spole\u010dnosti medac se n\u00e1\u0161 podnikatelsk\u00fd pl\u00e1n l\u00edbil a v\u00fdsledkem bylo, \u017ee p\u0159edlo\u017eil likvid\u00e1torovi nab\u00eddku na koupi v\u00fdrobny cytostatick\u00fdch injekc\u00ed. P\u0159es drobn\u00e9 nep\u0159\u00edjemnosti se to povedlo, 20. srpna roku 2010 podepsala spole\u010dnost oncomed manufacturing a. s. kupn\u00ed smlouvu, a 1. z\u00e1\u0159\u00ed 2010 m\u011bl oncomed sv\u00fdch prvn\u00edch deset zam\u011bstnanc\u016f. Od t\u00e9 doby st\u00e1le rosteme, z 10 zam\u011bstnanc\u016f je n\u00e1s nyn\u00ed 200. Poda\u0159ilo se n\u00e1m zprovoznit ob\u011b v\u00fdrobn\u00ed linky a za\u010d\u00edt na nich vyr\u00e1b\u011bt komer\u010dn\u00ed l\u00e9\u010div\u00e9 p\u0159\u00edpravky. A to byl teprve za\u010d\u00e1tek …<\/span><\/p>\n\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n
\n

2023<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

p\u0159ipojili jsme se k Pride Business Foru<\/h3>\n

P\u0159ipojen\u00ed k Pride Business F\u00f3ru zt\u011bles\u0148uje na\u0161e z\u00e1vazky k p\u0159ijet\u00ed na\u0161ich z\u00e1kladn\u00edch hodnot – \u010dlov\u011bk a otev\u0159enost. V r\u00e1mci t\u011bchto hodnot pln\u011b podporujeme rovnost, slav\u00edme rozmanitost a povzbuzujeme odvahu. Na\u0161\u00edm neot\u0159esiteln\u00fdm c\u00edlem je ct\u00edt a oce\u0148ovat ka\u017edou jednotlivou osobu na z\u00e1klad\u011b jej\u00ed lidskosti, bez ohledu na rozd\u00edly jako je pohlav\u00ed, rasov\u00e1 p\u0159\u00edslu\u0161nost, n\u00e1rodnost, n\u00e1bo\u017eenstv\u00ed, v\u011bk, vzd\u011bl\u00e1n\u00ed a dal\u0161\u00ed.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2023<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

\u00fasp\u011b\u0161n\u00fd FAT linky 3<\/h3>\n

V \u010dervenci 2023 prob\u011bhl \u00fasp\u011b\u0161n\u00fd Factory Acceptance Test (FAT) linky 3. \u00dasp\u011b\u0161n\u00e9 zakon\u010den\u00ed tohoto testu, znamen\u00e1, \u017ee linka je funk\u010dn\u00ed a provozuschopn\u00e1, a dodavatel ji tedy m\u016f\u017ee rozebrat, zabalit, a odeslat k n\u00e1m do oncomedu. Pot\u00e9 ji \u010dek\u00e1 ji\u017e jen postupn\u00e9 zprovozn\u011bn\u00ed.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2023<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

\u00fasp\u011b\u0161n\u00e9 p\u0159em\u00edst\u011bn\u00ed QC laborato\u0159\u00ed<\/h3>\n

\u00dasp\u011b\u0161n\u011b jsme p\u0159esunuli na\u0161e laborato\u0159e do nov\u00fdch prostor!<\/p>\n

Nov\u00e9 laborato\u0159e nab\u00edzej\u00ed nejmodern\u011bj\u0161\u00ed analytick\u00e1 za\u0159\u00edzen\u00ed, pokr\u00fdvaj\u00ed tak v\u0161echny nezbytn\u00e9 metody a z\u00e1rove\u0148 zaji\u0161\u0165uj\u00ed pohodln\u00e9 a modern\u00ed prost\u0159ed\u00ed pro na\u0161e analytiky.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2023<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

spoluzakladatel\u00e9 a \u010dlenov\u00e9 Life Sciences 4.0<\/h3>\n

C\u00edlem platformy Life Sciences 4.0 je\u00a0propojen\u00ed podnik\u016f z oblasti \u017eiv\u00fdch v\u011bd navz\u00e1jem a podnik\u016f s univerzitami. Platforma je zast\u0159e\u0161en\u00e1 Region\u00e1ln\u00ed hospod\u00e1\u0159skou komorou Brno a v\u00a0roce 2022 byla zformalizov\u00e1na do podoby spolku. Oncomed je jedn\u00edm ze spoluzakladatel\u016f a z\u00e1rove\u0148 \u010dlenem tohoto spolku.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2022<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

\u00fasp\u011b\u0161n\u00fd audit ANVISA<\/h3>\n

D\u00edky velk\u00e9mu \u00fasil\u00ed cel\u00e9ho na\u0161eho t\u00fdmu byl audit ANVISA \u00fasp\u011b\u0161n\u00fd. Na\u0161e produkty jsou nyn\u00ed certifikov\u00e1ny pro brazilsk\u00fd trh.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2021<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

recertifikace na ISO 45001<\/h3>\n

\u00dasp\u011b\u0161n\u011b jsme absolvovali audit na\u0161eho managementu bezpe\u010dnosti a ochrany zdrav\u00ed p\u0159i pr\u00e1ci<\/span> a obdr\u017eeli certifik\u00e1t ISO 45001, kter\u00fd nahradil p\u016fvodn\u00ed normu OHSAS.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2021<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

polo\u017een\u00ed z\u00e1kladn\u00edho kamene linky 3<\/h3>\n

Srpen byl p\u0159elomov\u00fdm m\u011bs\u00edcem. Poklep\u00e1n\u00edm z\u00e1kladn\u00edho kamene jsme potvrdili stavbu na\u0161\u00ed nov\u00e9 t\u0159et\u00ed linky.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2021<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

jsme \u010dleny \u010cAFF <\/h3>\n

Po \u010dervnov\u00e9m zased\u00e1n\u00ed \u010clensk\u00e9 sch\u016fze jsme se stali \u010dleny \u010cesk\u00e9 asociace farmaceutick\u00fdch firem. \u010cAFF sdru\u017euje od roku 2000 hlavn\u00ed v\u00fdrobce generick\u00fdch a biosimil\u00e1rn\u00edch l\u00e9k\u016f v \u010cesk\u00e9 republice a je \u010dlenem evropsk\u00e9 asociace farmaceutick\u00fdch firem Medicines For Europe.<\/p>\n

Hlavn\u00edm c\u00edlem je podpora rozvoje generick\u00fdch a biosimil\u00e1rn\u00edch l\u00e9\u010div\u00fdch p\u0159\u00edpravk\u016f a komunikace s p\u0159edstaviteli st\u00e1tn\u00ed spr\u00e1vy a zdravotnick\u00e9ho syst\u00e9mu, pl\u00e1tci, l\u00e9ka\u0159i a pacienty.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2019<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

jsme \u010dleny Business Leaders Fora<\/h3>\n

V l\u00e9t\u011b roku 2019 jsme se stali \u010dleny Business Leaders Fora, co\u017e je nejstar\u0161\u00ed platforma spole\u010densky odpov\u011bdn\u00fdch firem v \u010cesk\u00e9 republice, zalo\u017een\u00e1 v roce 1992, kter\u00e1 je sou\u010d\u00e1st\u00ed mezin\u00e1rodn\u00ed organizace CSR Europe. D\u00edky Business Leaders Foru m\u00e1me p\u0159\u00edle\u017eitost se setk\u00e1vat s ostatn\u00edmi firmami, kter\u00fdm nen\u00ed oblast spole\u010densk\u00e9 odpov\u011bdnosti lhostejn\u00e1, a z\u00e1rove\u0148 se z\u00e1stupci charit a nadac\u00ed, navz\u00e1jem se inspirovat, ukazovat si jin\u00e9 \u00fahly pohledu a nach\u00e1zet nov\u00e1 \u0159e\u0161en\u00edm jejich\u017e c\u00edlem je pos\u00edlit f\u00e9rov\u00e9 a odpov\u011bdn\u00e9 podnikatelsk\u00e9 prost\u0159ed\u00ed, kter\u00e9 obohacuje spole\u010dnost.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2019<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

povolen\u00ed pro hum\u00e1nn\u00ed hodnocen\u00e9 kapaln\u00e9 l\u00e9\u010div\u00e9 p\u0159\u00edpravky<\/h3>\n

V lednu 2019 jsme z\u00edskali povolen\u00ed k v\u00fdrob\u011b hodnocen\u00fdch kapaln\u00fdch l\u00e9\u010div\u00fdch p\u0159\u00edpravk\u016f, m\u00e1me tedy nyn\u00ed povolen\u00ed pro kapaln\u00e9 i lyofilizovan\u00e9 hodnocen\u00e9 i komer\u010dn\u011b vyr\u00e1b\u011bn\u00e9 p\u0159\u00edpravky.<\/span><\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2018<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

certifikace OHSAS<\/h3>\n

Na z\u00e1klad\u011b \u00fasp\u011b\u0161n\u00e9ho auditu na\u0161eho managementu bezpe\u010dnosti a ochrany zdrav\u00ed p\u0159i pr\u00e1ci jsme obdr\u017eeli mezin\u00e1rodn\u00ed certifik\u00e1t OHSAS.<\/span><\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2018<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

povolen\u00ed k z\u00edsk\u00e1n\u00ed hodnocen\u00fdch l\u00e9\u010div\u00fdch p\u0159\u00edpravk\u016f<\/h3>\n

V \u00fanoru 2018 jsme absolvovali inspekci St\u00e1tn\u00edho \u00fastavu pro kontrolu l\u00e9\u010div, j\u00ed\u017e do\u0161lo ke schv\u00e1len\u00ed roz\u0161\u00ed\u0159en\u00ed rozsahu v\u00fdroby o hum\u00e1nn\u00ed hodnocen\u00e9 l\u00e9\u010div\u00e9 p\u0159\u00edpravky.<\/span><\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2017<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

spolupr\u00e1ce na v\u00fdzkumu nov\u00e9 l\u00e9\u010div\u00e9 l\u00e1tky<\/h3>\n

Za\u010dali jsme spolupracovat na v\u00fdzkumu nov\u00e9 l\u00e9\u010div\u00e9 l\u00e1tky pro l\u00e9\u010dbu rakovinn\u00fdch onemocn\u011bn\u00ed. <\/span><\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2012<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

energetick\u00e9 centrum<\/h3>\n

Na podzim jsme dokon\u010dili stavbu energetick\u00e9ho centra vyu\u017e\u00edvaj\u00edc\u00edho kogenera\u010dn\u00ed jednotku. Po ud\u011blen\u00ed licence na v\u00fdrobu elekt\u0159iny <\/span>za\u010d\u00edn\u00e1me s v\u00fdrobou technologick\u00e9 p\u00e1ry, topn\u00e9 vody a elektrick\u00e9 energie pot\u0159ebn\u00e9 pro chod na\u0161ich v\u00fdrobn\u00edch linek<\/span><\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2012<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

roz\u0161\u00ed\u0159en\u00ed v\u00fdrobn\u00edch kapacit<\/h3>\n

Poda\u0159ilo se n\u00e1m zprovoznit linku 2 spole\u010dn\u011b s termin\u00e1ln\u00edm steriliz\u00e1torem. \u00dasp\u011b\u0161n\u011b proch\u00e1z\u00edme dal\u0161\u00edm auditem St\u00e1tn\u00edho \u00fastavu pro kontrolu l\u00e9\u010div, z\u00edsk\u00e1v\u00e1me povolen\u00ed k v\u00fdrob\u011b l\u00e9\u010div\u00fdch p\u0159\u00edpravk\u016f na lince 2 a certifik\u00e1t SVP. <\/span><\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2011<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

odstartov\u00e1n\u00ed v\u00fdroby komer\u010dn\u00edch l\u00e9\u010div<\/h3>\n

Zprovoz\u0148ujeme prvn\u00ed linku pro v\u00fdrobu cytostatick\u00fdch injekc\u00ed. \u00dasp\u011b\u0161n\u011b proch\u00e1z\u00edme auditem St\u00e1tn\u00edho \u00fastavu pro kontrolu l\u00e9\u010div. Z\u00edsk\u00e1v\u00e1me povolen\u00ed k v\u00fdrob\u011b l\u00e9\u010div\u00fdch p\u0159\u00edpravk\u016f na lince 1 a certifik\u00e1t SVP.<\/span><\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

2010<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

zalo\u017een\u00ed spole\u010dnosti<\/h3>\n

Spole\u010dnost oncomed byla ofici\u00e1ln\u011b zalo\u017eena v srpnu 2010. V z\u00e1\u0159\u00ed 2010 u n\u00e1s za\u010dalo pracovat na\u0161ich prvn\u00edch deset zam\u011bstnanc\u016f. Zapo\u010dali jsme s procesem zprovozn\u011bn\u00ed v\u00fdrobn\u00edch linek a se stavbou na\u0161eho laboratorn\u00edho centra kontroly kvality, vizu\u00e1ln\u00ed kontroly a expedice.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n

\n
\n

<\/h4>\n \n <\/div>\n
<\/div>\n
\n
\n

<\/h3>\n
<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"class_list":["post-164","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"coauthors":[],"author_meta":{"author_link":"https:\/\/www.oncomed.cz\/cs\/author\/veronika-cepcekova\/","display_name":"Veronika Cepcekova"},"relative_dates":{"created":"Posted 6 roky ago","modified":"Updated 2 roky ago"},"absolute_dates":{"created":"Posted on 8. 9. 2020","modified":"Updated on 16. 1. 2024"},"absolute_dates_time":{"created":"Posted on 8. 9. 2020 22:53","modified":"Updated on 16. 1. 2024 9:32"},"featured_img_caption":"","featured_img":false,"series_order":"","_links":{"self":[{"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/pages\/164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/comments?post=164"}],"version-history":[{"count":5,"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/pages\/164\/revisions"}],"predecessor-version":[{"id":58688,"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/pages\/164\/revisions\/58688"}],"wp:attachment":[{"href":"https:\/\/www.oncomed.cz\/cs\/wp-json\/wp\/v2\/media?parent=164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}